Abstract
Extensive bone defects in maxillofacial region can be corrected with autogenous grafts; otherwise, the disadvantages of the therapeutics modality take the research for new bone substitutes. Considering this, the use of osteoinductive factors, platelet derived growth factor (PDGF-BB) have been an alternative. Otherwise, carriers and scaffolds are essential to maintain the osteoinduction ca…